Study hints antibody drug may cut COVID-19 hospitalizations

In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. On Wednesday, Sept. 16, 2020, Lilly said that partial results from a study testing an antibody drug in mild to moderately ill COVID-19 patients give hints that the drug may help keep them from needing to be hospitalized. But the results have not been published or reviewed by independent scientists. (David Morrison/Eli Lilly via AP)

In this May 2020 photo provided by Eli Lilly, a researcher tests possible COVID-19 antibodies in a laboratory in Indianapolis. On Wednesday, Sept. 16, 2020, Lilly said that partial results from a study testing an antibody drug in mild to moderately ill COVID-19 patients give hints that the drug may help keep them from needing to be hospitalized. But the results have not been published or reviewed by independent scientists. (David Morrison/Eli Lilly via AP)

To view this content you must be logged in as a subscriber.
Already have a digital account? Log in here
4 WEEKS
$12.50

UNLIMITED

DIGITAL ACCESS

4 WEEKS

52 WEEKS
$135

UNLIMITED

DIGITAL ACCESS

FOR 52 WEEKS

DAY PASS
$2.00

UNLIMITED

DIGITAL ACCESS

FOR 24 HOURS

Plans include full website access, e-Edition and exclusive online extras.
Print and Digital combo plans also available.
ALREADY A PRINT SUBSCRIBER?
dcourier subscribe logo

Donate Report a Typo Contact
Most Read